Abstract
Background
Xylitol is a well-known anticaries agent and has been used for the prevention and treatment of dental caries. In this study, the anti-inflammatory effects of xylitol are evaluated for possible use in the prevention and treatment of periodontal infections.
Methods
Cytokine expression was stimulated in THP-1 (human monocyte cell line)-derived macrophages by live Porphyromonas gingivalis, and enzyme-linked immunosorbent assay and a commercial multiplex assay kit were used to determine the effects of xylitol on live P. gingivalis–induced production of cytokine. The effects of xylitol on phagocytosis and the production of nitric oxide were determined using phagocytosis assay, viable cell count, and Griess reagent. The effects of xylitol on P. gingivalis adhesion were determined by immunostaining, and costimulatory molecule expression was examined by flow cytometry.
Results
Live P. gingivalis infection increased the production of representative proinflammatory cytokines, such as tumor necrosis factor-α and interleukin (IL)-1β, in a multiplicity of infection– and time-dependent manner. Live P. gingivalis also enhanced the release of cytokines and chemokines, such as IL-12 p40, eotaxin, interferon γ–induced protein 10, monocyte chemotactic protein-1, and macrophage inflammatory protein-1. The pretreatment of xylitol significantly inhibited the P. gingivalis– induced cytokines production and nitric oxide production. In addition, xylitol inhibited the attachment of live P. gingivalis on THP-1-derived macrophages. Furthermore, xylitol exerted anti-phagocytic activity against both Escherichia coli and P. gingivalis.
Conclusion
These findings suggest that xylitol acts as an antiinflammatory agent in THP-1-derived macrophages infected with live P. gingivalis, which supports its use in periodontitis.
Keywords: Cytokines, inflammation, periodontitis, Porphyromonas gingivalis, xylitol
Inflammation is essential for the host defense against invading pathogens and for tissue repair.1 Periodontitis is a chronic inflammatory disease induced by infection of major periodontopathogens, such as Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola.2,3 Chronic inflammation affects the periodontal tissues, resulting in a loss of alveolar bone and teeth.4 Periodontopathogens such as P. gingivalis have been detected frequently in atherosclerotic plaques, indicating a potential causal relationship between oral inflammatory diseases and various vascular diseases.5–8 P. gingivalis, an oral black-pigmented anaerobic Gramnegative bacterium, can penetrate the gingival tissue and move into the blood circulation, leading to systemic inflammatory responses, such as atherosclerosis. As a response to infection, inflammatory immune cells, such as monocytes and macrophages, are recruited to the periodontitis tissuesandproduce cytokines and chemokines, which in turn activate an adaptive immune response.9 Therefore, the host innate immune system plays a critical role in the rapid recognition and elimination of invading pathogens through phagocytosis and the induction of inflammation.
Phagocytosis is a key mechanism of innate immunity that is mediated by professional phagocytes, such as peripheral blood mononuclear and macrophage cells.10 Phagocytes play important roles in the host innate immune defense against infection of pathogens and in inducing adaptive immune responses. The response of a phagocyte to a pathogen involves several steps, including the detection of pathogens through surface receptors and engulfing of pathogens.
Cytokines, small soluble signaling factors, are secreted by immune cells and play essential roles in immune modulation and activation of various immune cells. Although these secreted cytokines play protective roles in the elimination of infected bacteria, overproduction of proinflammatory cytokines might be directly relevant to periodontal breakdown, such as periodontal attachment loss (AL), breakdown of collagen, and alveolar bone resorption.11,12 Therefore, understanding these cytokine abnormalities may be beneficial in identifying the pathogenesis of periodontitis and developing an effective therapeutic approach.
Xylitol is a naturally occurring, low-calorie sugar substitute that is considered to be non-fermentable by oral bacteria. It inhibits bacterial growth and metabolism, as well as the polysaccharide production of mutans streptococci, exhibiting both anticariogenic and cariostatic properties.13–15 Previously, it was reported that xylitol has an anti-inflammatory effect by inhibiting cytokine production induced by P. gingivalis lipopolysaccharide (LPS) in Raw 264.7 cells.16 However, the anti-inflammatory effects of xylitol on live P. gingivalis remains to be elucidated. The immune responses to live bacteria might not be initiated simply by the bacteria cell surface virulence factors. The profiling of cytokines produced by human macrophages secreted by LPS or FimA (Type-1 fimbrial protein, A chain) differed substantially from what was observed when the cells were infected with live P. gingivalis.17 The host defense system senses live bacteria differently from individual bacterial components, and thus it stimulates a different set of immune responses. Thus, the prevention of periodontitis would be improved if the anti-inflammatory mechanism of macrophages infected with live P. gingivalis could be identified.
In the present study, the P. gingivalis–induced inflammatory response and the effect of xylitol on the production of inflammatory cytokines and nitric oxide (NO), as well as phagocytosis elicited by live P. gingivalis in THP-1-derived macrophages is investigated. The purpose of the present study is to elucidate immunomodulatory effects of xylitol, aiming for the future application of xylitol in chronic periodontitis (CP).
MATERIALS AND METHODS
Bacterial Culture
P. gingivalis (strain 381) were grown in gifu anaerobic medium (GAM)§ broth, which contained 5 mg/mL hemin|| and 0.5 mg/mL 3-phytyl-menadione¶ (vitamin K) at 37°C in an anaerobic chamber in an atmosphere containing 90% N2, 5% H2, and 5% CO2. An optical density (OD) of 1.0 (650 nm) was determined to correlate to 109 colony forming units/mL. To prepare the bacteria for infection, an overnight culture was diluted to an OD 650 nm of 1.0 in GAM broth. The bacteria were washed once, resuspended in Roswell Park Memorial Institute (RPMI)# media, and used to infect the macrophages at a set macrophage/P. gingivalis ratio of 1:10, 1:20, 1:50, or 1:100.
Cell Culture
The human monocyte cell line THP-1 was obtained from a commercial source,** and the authors were not able to ascertain the identity of the donors. It wasmaintained in RPMI 1640 medium supplemented with 10% fetal bovine serum,†† 100 U/mL penicillin, and 100 μg/mL streptomycin and was incubated at 37°C in a humidified atmosphere of 5% CO2. THP-1 cells were differentiated into macrophage-like cells with 50 nM phorbol 12-mystristate 13-acetate‡‡ (PMA). The differentiated cells were pretreated with 3% xylitol for 30 minutes before treatment with live P. gingivalis. After incubation of P. gingivalis for 90 minutes, cells were washed with phosphate-buffered saline (PBS) and incubated further with 3% xylitol§§ for 6 or 24 hours.
3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) Assay
MTT experiments were performed to determine the cell growth rates in the culture media after xylitol treatment. Briefly, the THP-1 cells were plated in a 96-well plate. After 6 or 24 hours of xylitol treatment, cells were incubated with 100 μL of an MTT solution|||| of 1 μg/μL at 37°C for 4 hours. The purple formazan crystal was dissolved in 100 μL dimethylsulfoxide and added to the cells. The absorbance was measured using a spectrophotometer at 570 nm.
Measurement of Tumor Necrosis Factor (TNF)-α and Interleukin (IL)-1β
To determine the amount of TNF-α and IL-1β released into the culture media after P. gingivalis stimulation, the amount was analyzed in accordance with the instructions of the manufacturer using enzyme-linked immunosorbent assay (ELISA) kits.¶¶
Measurement of Cytokines and Chemokines
To determine the quantity of cytokines and chemokines released into the culture media after P. gingivalis stimulation, the amount was analyzed according to the instructions of the manufacturer using a multiplex assay kit.## Briefly, standard or sample solution and mixed beads were added to an ELISA well plate. After overnight incubation at 4°C with shaking, detection antibodies were added to the solution and incubatedfor1hourat roomtemperature. Streptavidin– phycoerythrin was added and allowed to react for 30 minutes. After incubation, the levels of cytokine and chemokine expression were assessed using software.***
NO Measurement
The cell supernatants after P. gingivalis stimulation were used to measure the NO concentration using a Griess reagent system.†††
Viable Cell Count
P. gingivalis were harvested, washed, and re-suspended in RPMI medium without antibiotics. The THP-1-derived macrophages were pretreated with 3% xylitol for 30 minutes and then exposed to P. gingivalis (multiplicity of infection [MOI] of 50) for 90 minutes at 37°C in a humidified atmosphere of 5% CO2. To enumerate P. gingivalis associated with macrophages, cells were washed three times with chilled PBS to remove the non-adherent bacteria and lysed in sterile distilled water for 20 minutes. The cell lysates were diluted with GAM broth and plated on blood agar supplemented with hemin and vitamin K. The viable cells were counted after incubation in anaerobic conditions for 7 days at 37°C. To count the internalized bacteria, the macrophages were infected with P. gingivalis as above and cultured for an additional 1 hour in the presence of 200 μg/mL metronidazole and gentamicin. The cells were then washed and lysed in sterile distilled water, and the bacterial number was counted. P. gingivalis colonies were identified by their characteristic black pigment and then enumerated.
Phagocytosis Assay
To measure the effects of xylitol on phagocytic function, the net phagocytosis and response to xylitol were calculated according to the instructions of the manufacturer using a phagocytosis assay kit.‡‡‡ Briefly, the THP-1-derived macrophages were treated with 3% xylitol for 30 minutes or 1 hour. After xylitol incubation time, the media were removed, and fluorescein-labeled Escherichia coli K-12 bioparticles were added and incubated for an additional 2 hours. After quenching with trypan blue solution, the microplates were read in the fluorescence plate reader using 480 nm and 520 nm.
To determine the effects of xylitol on P. gingivalis phagocytic function, P. gingivalis were labeled with 10 μM carboxyfluorescein diacetate succinimidyl ester§§§ in PBS containing 0.1% bovine serum albumin (BSA) for 10 minutes at 37°C. THP-1-derived macrophages were treated with 3% xylitol for 30 minutes. After xylitol treatment, the media were removed, and fluorescein-labeled P. gingivalis were challenged for 2 hours. After quenching with trypan blue solution, the microplates were read in the fluorescence plate reader|||||| using 480 nm and 520 nm.
Immunostaining
THP-1 cells were differentiated into macrophages with 50 nM PMA placed on eight-well chamber slides.¶¶¶ THP-1-derived macrophages were pre-treated with xylitol for 30 minutes before stimulation with live P. gingivalis, which were labeled with 10 μM CFSE in PBS containing 0.1% BSA for 10 minutes at 37°C. After 90 minutes of incubation, the cells were washed three times in PBS and fixed with 4% para-formaldehyde### for 10 minutes at room temperature and permeabilized for 5 minutes with PBS containing 0.1% non-ionic surfactant.**** The cells were blocked with signal enhancer†††† for 30 minutes and then stained with red fluorescent dye‡‡‡‡ (1:200 in blocking buffer) for 20 minutes at room temperature. After washing with PBS, the chamber slides were mounted with antifade reagent§§§§ with 4′,6-diamidino-2-phenylindole (DAPI) andmonitored using confocal laser-scanning microscopy.||||||||
Fluorescent Staining and Flow Cytometry
To detect the expression of costimulatory molecules on human monocytes, THP-1 cells were harvested and stained with fluorescent-labeled antibodies against anti-human cluster of differentiation 80 (CD80; B7-1) fluorescein isothiocyanate and antihuman CD86 (B7-2) phycoerythrin¶¶¶¶ as recommended by the manufacturer. Briefly, THP-1 cells were collected with cold PBS, washed in staining buffer (PBS, 2% BSA), and then stained in PBS supplemented with 2% BSA for 1 hour on ice with CD80 and CD86 antibodies. Cells were washed twice with buffer. Samples were acquired using a flow cytometer#### and analyzed using data analysis software.*****
Statistical Analyses
Statistically significant differences among samples were analyzed with an unpaired, one-tailed Student t test. The data are shown as the mean ± SD. A P value <0.05 was considered statistically significant.
RESULTS
Xylitol Inhibited the Release of TNF-α and IL-1β Induced by Live P. gingivalis Infection
Before performing the experiments to examine the effect of xylitol on P. gingivalis–stimulated inflammatory response in THP-1-derived macrophages, an optimal concentration of xylitol was determined. THP-1 cells were treated with different concentrations of xylitol ranging from 0.125% to 24% for 6 or 24 hours, to examine the effects of xylitol on the viability of THP-1-derived macrophage cells. After incubation, the viability of cells was measured by an MTT assay. Compared to the untreated control cells, the viability of THP-1-derived macrophages was reduced by higher concentrations of xylitol (Figs. 1A and 1B). Next, the effects of xylitol concentration on proinflammatory cytokine production induced by live P. gingivalis infection were examined. THP-1-derived macrophages were stimulated with live P. gingivalis at an MOI of 50. Apparent active release of TNF-α and IL-1β by live P. gingivalis challenge was detected by ELISA in culture supernatants for 6 and 24 hours (Figs. 2A through 2D). The production of these cytokines was inhibited significantly by treatment with 3% xylitol. From these results, 3% xylitol was selected because it does not cause cytotoxicity or have anti-inflammatory effects on THP-1-derived macrophages. The effects of xylitol on proinflammatory cytokine production induced by live P. gingivalis infection in an MOI-dependent manner was further analyzed. THP-1-derived macrophages were stimulated with live P. gingivalis at an MOI of 10, 20, 50, or 100. Live P. gingivalis–induced TNF-α and IL-1β production was inhibited significantly by xylitol treatment (Figs. 3A through 3D). The results suggest that xylitol negatively regulates the production of proinflammatory cytokines induced by live P. gingivalis infection in THP-1-derived macrophages.
Figure 1.
The cytotoxic effects of xylitol on the THP-1-derived macrophages. THP-1-derived macrophages were treated with indicated concentrations of xylitol for 6 (A) or 24 (B) hours, and the cytotoxicity was measured by MTT assay. *P <0.05 compared to control.
Figure 2.
The production of TNF-α and IL-1β induced by live P. gingivalis (Pg) infection was inhibited by xylitol treatment in a concentration-dependent manner. The THP-1-derived macrophages were pretreated with 0.5%, 1%, 2%, and 3% xylitol for 30 minutes and then infected with live P. gingivalis (MOI of 50) for 6 hours (A and C) or 24 hours (B and D). Cell culture supernatant was assayed for human TNF-α (A and B) and IL-1β (C and D) using ELISA. The data represent mean ± SD values (n ≥3). *P <0.05 compared to control cells. †P <0.05 compared to P. gingivalis–infected cells.
Figure 3.
Xylitol inhibited the dose- and time-dependent release of TNF-α and IL-1β induced by live P. gingivalis (Pg) infection. The THP-1-derived macrophages were pretreated with 3% xylitol for 30 minutes and then infected with live P. gingivalis (MOI of 10, 20, 50, and 100) for 6 hours (A and C) or 24 hours (B and D). Cell culture supernatantswere assayed for humanTNF-α(A and B) and IL-1β(C andD) using ELISA. The data representmean ± SD values (n≥3).*P <0.05 compared to control cells. †P <0.05 compared to P. gingivalis–infected cells.
Xylitol Inhibited the Production of Cytokines, Chemokines, and NO Induced by Live P. gingivalis Infection
To investigate the effects of live P. gingivalis infection on the production of various cytokines and chemokines, a multiplex assay was performed in THP-1-derived macrophages. Live P. gingivalis infection (MOI of 50 or 100) increased the production of IL-12 p40, eotaxin, interferon γ–induced protein 10 (IP-10; chemokine [C-X-C motif] ligand [CXCL10]), monocyte chemotactic protein-1 (MCP-1; CC chemokine ligand 2 [CCL2]), and macrophage inflammatory protein-1 (MIP-1α; CCL3), as well as TNF-α and IL-1β, for 6 or 24 hours. The production of cytokines and chemokines was inhibited by xylitol pretreatment (Figs. 4A through 4G and 5A through 5G). NO is an important cellular signaling molecule that is generated by macrophages. Next, to further explore the effect of xylitol on NO production, whether live P. gingivalis infection increases NO production in THP-1-derived macrophages was examined. As shown in Figures 4H and 5H, NO was produced in response to P. gingivalis infection (MOI of 50 or 100) for 6 or 24 hours. In addition, NO production stimulated by live P. gingivalis infection was reduced by xylitol pretreatment (Figs. 4H and 5H). Overall, these results suggest that xylitol inhibits the production of inflammatory cytokines, chemokines, andNOinduced by live P. gingivalis infection.
Figure 4.
Xylitol inhibited the dose- and time-dependent release of cytokines (A,B, and C), chemokines (D,E,F, and G), andNO(H) induced by live P. gingivalis (Pg) infection. The THP-1-derived macrophages were pretreated with 3% xylitol for 30 minutes before infection with live P. gingivalis (MOI of 50 or 100) for 6 hours. The concentration of cytokines (TNF-α (A), IL-1β (B), and IL-12 p40 (C)) and chemokines (eotaxin (D), IP-10 (E),MCP-1 (F), andMIP-1α (G)) in the culture supernatants was analyzed using a multiplex assay kit. For NO (H) concentration, culture supernatant was assayed using Griess reagent system. *P <0.05 compared to the control cells. †P <0.05 compared to the P. gingivalis–infected cells.
Figure 5.
Cytokines (A,B, and C), chemokines (D,E,F, and G), and NO (H) induced by live P. gingivalis (Pg) infection were inhibited by xylitol treatment in a dose-dependentmanner. The THP-1-derivedmacrophageswere pretreatedwith3%xylitol for 30minutes before infectionwith live P. gingivalis (MOI of 50 or 100) for 24 hours. The cytokines and chemokines concentrations in the culture supernatants were analyzed using a multiplex assay kit. For NO concentration, culture supernatantwas assayed using aGriess reagent system.*P <0.05 compared to the control cells. †P <0.05 compared to the P. gingivalis–infected cells.
Xylitol Inhibited Adhesion, Internalization, and Phagocytosis of Live P. gingivalis
Live P. gingivalis was first examined to determine whether it could attach to THP-1-derived macrophages. As shown in Figure 6A, live P. gingivalis attached and internalized to THP-1-derived macrophages according to the viable cell count, as described in Materials and Methods. Pretreatment of xylitol inhibited the adhesion and internalization of P. gingivalis to THP-1-derived macrophages, although it was statistically insignificant. To visualize the attachment of live P. gingivalis on THP-1-derived macrophages, immunofluorescence analysis was next performed with CFSE-stained live P. gingivalis. Attachment of live P. gingivalis was detected on THP-1-derived macrophages in culture, whereas adhesion was inhibited significantly by xylitol pretreatment (Fig. 6B). Additional experiments were performed to determine whether xylitol regulates the phagocytic activity of THP-1-derived macrophages. Before the examination, the effects of xylitol on phagocytic efficacy against E. coli particles were investigated to determine how xylitol acts on the phagocytosis of live P. gingivalis. As shown in Figure 6C, xylitol negatively regulates phagocytosis of E. coli particles. Next, the effects of xylitol on the phagocytic function of THP-1-derived macrophages against live P. gingivalis were observed using CFSE-stained live P. gingivalis. The phagocytic function against live P. gingivalis at MOIs of 50 and 100 was inhibited by xylitol pretreatment (Fig. 6D). These results suggest that xylitol inhibits P. gingivalis attachment and phagocytic function of THP-1-derived macrophages against live P. gingivalis. In addition, live P. gingivalis stimulated the expression of costimulatory molecules, CD80 and CD86, in THP-1-derived macrophages, as shown in Figures 6E and 6F. Conversely, upregulated CD80 and CD86 expression was not altered by xylitol pretreatment (Figs. 6E and 6F). These results suggest that xylitol does not play a role in the regulation of CD80 and CD86 expression induced by live P. gingivalis infection.
Figure 6.
A)Xylitol inhibited the adhesion and the internalization of live P. gingivalis (Pg). For viable cell count assay, the THP-1-derived macrophages were pretreated with 3% xylitol for 30 minutes before infection with live P. gingivalis (MOI of 50) for 90 minutes (adhesion assay) or 6 hours (internalization assay). B) The adhesion of P. gingivalis was inhibited by xylitol treatment. The THP-1-derived macrophages were pretreated with 3% xylitol for 30 minutes before infection with CFSE-stained live P. gingivalis for 90 minutes and then immunostained with red fluorescent dye. The nucleus was stained with DAPI and observed by confocal microscopy. C)Xylitol negatively regulated phagocytic function of THP-1 cells. The THP-1-derived macrophages were treated with 3%xylitol for 0.5 or 1 hour, and phagocytic efficacy for fluorescein-labeled E. coli K-12 bioparticles was calculated. D) Phagocytosis against P. gingivalis was inhibited by xylitol pretreatment. The THP-1-derivedmacrophageswere pretreatedwith 3%xylitol for 30minutes before infectionwith CFSE-stained live P. gingivalis(MOI of 50 or 100) for 2 hours. E and F) Xylitol did not regulate the expression of CD80 and CD86 molecules induced by live P. gingivalis infection. THP-1 cells were pretreated with 3%xylitol for 30 minutes before infection with live P. gingivalis (MOI of 50) for 90 minutes. E) Flow cytometry dot plots shows the percentages of cells expressing CD80 and CD86 molecules. Results represent one of three individual experiments. F) The numbers represent the percentage of cells, CD80, CD86, and CD80/86 monocytes. The results are expressed as themean ± SD of three independent experiments. *P <0.05 compared to the control cells. †P <0.05 compared to the P. gingivalis–infected cells. CFU = colony forming units; ns = not significant; Ct = control (without treatment).
DISCUSSION
In this study, the anti-inflammatory effects of xylitol on live P. gingivalis infection in THP-1-derived macrophages are examined. Xylitol efficiently inhibited the production of cytokines and chemokines induced by live P. gingivalis infection. NO production stimulated by live P. gingivalis was inhibited by xylitol pretreatment. Moreover, xylitol had inhibitory effects on the phagocytic activity against P. gingivalis and reduced P. gingivalis attachment to THP-1-derived macrophages.
Periodontitis is a major cause of adult tooth loss and is closely related to chronic inflammation caused by P. gingivalis infection.5,6 The host innate immune system produces inflammatory cytokines and chemokines against bacterial infection.18 Although cytokines produced by bacterial infection play protective roles in the elimination of bacteria, the overproduction of proinflammatory cytokines might be related directly to periodontal breakdown, such as periodontal AL, breakdown of collagen, and alveolar bone resorption.3,6,18 Therefore, the tight regulation of cytokine secretion is required for the treatment of periodontitis.
To the best of the authors’ knowledge, it is shown here for the first time that live P. gingivalis infection leads to secretion of various proinflammatory cytokines and chemokines, including IL-12, eotaxin, IP-10, MCP-1, and MIP-1α, as well as TNF-α and IL-1β in THP-1-derived macrophages. The major secreted proinflammatory cytokines TNF-α and IL-1β are the markers of periodontitis progression and severity and principle inducers of effector molecules that cause the breakdown of periodontal tissues.12,19,20 IL-12 increases natural killer (NK) cell production and is an important factor in CD4+ cell differentiation to T-helper 1 (Th1) or Th2 T cells.21 The level of IL-12 p40 is reported to be significantly higher in CP sites than healthy sites and is produced by LPS of periodontopathogens. 22 Eotaxin is a member of the CC chemokine family with preferential chemotactic capacity for eosinophil.23 Eotaxin is also expressed strongly in patients with periodontitis, but no relationship has been established between periodontal disease and eotaxin until now.24 IP-10 (CXCL10), an immunoregulatory cytokine, has been discovered in various infectious diseases and mediates leukocyte trafficking.25 It also activates T lymphocytes, B lymphocytes, NK cells, macrophages, and dendritic cells.26 MCP-1 (CCL2) is a CC chemokine responsible for chemotaxis of monocytes and is increased in the crevicular fluids of adult periodontal patients with severe disease.27–30 MIP-1α (CCL3) induces the synthesis and the release of other proinflammatory cytokines, such as IL-1, IL-6, and TNF-α, from macrophages.31,32 MIP-1α is increased in patients with periodontitis.24 In the present study, during stimulation by live P. gingivalis infection, macrophages produced and released the inflammatory cytokines, such as TNF-α, IL-1β, and IL-12, that modulate most of the macrophage functions and cell surface marker expression and the chemokines, such as eotaxin, IP-10, MCP-1, and MIP-1 that contribute to the recruitment of circulating monocytes within tissues. These strongly expressed cytokines and chemokines play a potential role in the breakdown of periodontal tissue. Cytokines and other bacterial products stimulate the expression of NO and enhance the progression of periodontal disease. NO is a multifunctional signaling molecule that regulates important cellular events in inflammation. 33 Overproduction of NO caused by activated macrophages has been linked to the pathogenesis of a number of diverse effects, including direct cellular cytotoxicity and various inflammatory processes and resulting in periodontal tissue breakdown. NO has been linked to etiopathogenesis of inflammatory periodontal diseases and is expressed strongly in the saliva of patients with periodontitis compared with the controls.34,35 In this study, it is shown that infection of live P. gingivalis increased NO production in THP-1-derived macrophages.
Previously, xylitol was reported to inhibit bacterial growth and metabolism exhibiting both non-cariogenic and cariostatic properties.14,15 In addition, xylitol has anti-inflammatory effects by inhibiting the production of cytokines induced by P. gingivalis LPS in Raw 264.7 cells.16 From these studies, it was hypothesized that xylitol could inhibit the production of proinflammatory cytokines induced by live P. gingivalis infection. In line with this, to the best of the authors’ knowledge, this study showed for the first time that xylitol effectively inhibits the production of inflammatory cytokines, such as TNF-α, IL-1β, IL-12, and eotaxin, and chemokines, such as IP-10, MCP-1, and MIP-1α, and NO, which were induced by live P. gingivalis infection in THP-1-derived macrophages. These results suggest that xylitol has an anti-inflammatory effect against live P. gingivalis infection, and in turn, the possible use of xylitol as an anti-inflammatory agent for the control of CP is suggested. Additional studies will be needed to determine whether xylitol exerts the anti-inflammatory effects not only on the stabilized cell line but also on peripheral blood monocytes. Therefore, it is also important to examine anti-inflammatory effects of xylitol in animal models to support the role of xylitol in periodontitis in vivo. These results also showed that live P. gingivalis can attach to the surface of THP-1-derived macrophages and was internalized into the cells. In line with this, P. gingivalis was also shown to be phagocytized into THP-1-derived macrophages. These phenomena were decreased by xylitol pretreatment. Phagocytes first detect bacteria using cell surface receptors and then engulf and kill the bacteria.10 In addition, phagocytes produce proinflammatory cytokines and chemokines that regulate local and systemic inflammatory responses and direct the development of adaptive immunity. Phagocytic receptors may trigger internalization of bacteria in general non-specific ways. Macrophages activated with soluble LPS, a ligand for Toll-like receptor 4 (TLR4), were shown to exhibit the increases in membrane ruffling, adhesion, and mortality, all of which enhance the binding and uptake of bacteria.36–38 These phenomena were suggested to contribute to the innate immune receptors. Stimulation of TLRs increases phagocytosis of Gram-positive Streptococcus pneumoniae by microglia, and TLR agonist increases the phagocytosis of fungi and bacteria significantly, suggesting the role of TLRs as phagocytic receptors.39,40 Both TLR2 and TLR4 recognize P. gingivalis, and these phagocytic receptors can trigger the responses to be effective against the bacteria.41,42 P. gingivalis are invasive bacteria and can survive in the macrophages. In addition, this study then examined whether heat-killed (HK) P. gingivalis induced cytokine production in THP-1-derived macrophages. Infection of HK P. gingivalis could not promote the secretion of TNF-α and IL-1β compared to a live P. gingivalis infection (authors’ unpublished data), suggesting that live P. gingivalis induces strong cellular immunologic responses. To determine how phagocytosis influences P. gingivalis infection, cytokine expression after cytochalasin D, an inhibitor of actin-dependent phagocytosis treatment, was also examined. Live P. gingivalis–induced cytokine production was inhibited by treatment with cytochalasin D (the authors’ unpublished data), suggesting that phagocytosis is required for the secretion of cytokine. Activated phagocytosis of macrophages enhances the production of several proinflammatory cytokines. Therefore, inhibiting phagocytosis during invasive bacterial infection may prevent inflammatory responses. The underlying mechanism of phagocytosis inhibition could be mediated by several ways, such as by regulating expression of phagocytic receptors of macrophages or by modulating the interaction between the bacteria and host receptors. Additional study will be needed to elucidate the detailed mechanism for the inhibition of phagocytosis by xylitol. Moreover, the elucidation of phagocytic response to in vivo infection with live P. gingivalis might provide new insight into the treatment of periodontitis, which requires additional studies using animal models.
CD80 and CD86 molecules can regulate inflammation in innate immunity via macrophage contact and are important in macrophage function as antigen-presenting cells and phagocytes. They provide a major costimulatory signal for the activation of T cells through the T-cell counter receptor CD28 molecule.43 Therefore, whether xylitol plays a modulatory role in the expression of the monocyte surface molecules CD80 and CD86 induced by live P. gingivalis infection was subsequently examined. Similar to a previous study showing that large numbers of CD80- and CD86-expressing cells were identified in periodontitis lesions,44,45 these results showed that live P. gingivalis infection stimulated the expression of costimulatory molecules CD80 and CD86, suggesting their role in mediating immune responses to microbial infection. Conversely, this stimulation of CD80 and CD86 expression was unaffected by xylitol pretreatment, suggesting that xylitol does not regulate the expression of costimulatory molecules.
CONCLUSIONS
Live P. gingivalis increased the release of cytokines and chemokines, such as TNF-α, IL-1β, IL-12 p40, eotaxin, IP-10, MCP-1, and MIP-1α, in THP-1-derived macrophages. The pretreatment with xylitol significantly decreased the production of cytokines, chemokines, and NO induced by live P. gingivalis infection. Xylitol also inhibited the attachment of live P. gingivalis to THP-1-derived macrophages. Furthermore, xylitol has effects on the antiphagocytic activity against both E. coli and P. gingivalis in THP-1-derived macrophages. These findings suggest that xylitol acts as an anti-inflammatory agent against live P. gingivalis infection, highlighting its potential clinical use in the prevention or treatment of periodontitis.
Acknowledgments
This studywas supported by National Research Foundation of Korea Grant 2012R1A2A2A01015470 funded by Ministry of Education, Science, and Technology.
Footnotes
Nissui, Tokyo, Japan.
Sigma-Aldrich, St. Louis, MO.
Sigma-Aldrich.
Gibco, Thermo Fisher Scientific, Waltham, MA.
Korean Cell Line Bank, Seoul, Korea.
Gibco, Thermo Fisher Scientific.
Sigma-Aldrich.
Danisco Sweeteners, Kotka, Finland
Sigma-Aldrich.
eBioscience, San Diego, CA.
MILLIPLEX MAP Kit, Millipore, Billerica, MA.
MAGPIX with xPONENT software, Millipore.
Promega, Madison, WI.
Vybrant Phagocytosis Assay Kit, Invitrogen.
CellTrace CFSE, Invitrogen, Thermo Fisher Scientific.
GLOMAX multi-detection system, Promega.
LabTec, Nunc, Thermo Fisher Scientific.
Electron Microscopy Sciences, Hatfield, PA.
0.1% Triton X-100, Amersham, GE Health Care, Little Chalfont, U.K.
Image-iT FX signal enhancer, Invitrogen, Thermo Fisher Scientific.
Alexa Fluor 633 phalloidin, Gibco, Thermo Fisher Scientific.
Prolong Gold antifade reagent, Gibco, Thermo Fisher Scientific.
LSM 700, Carl Zeiss, Jena, Germany.
eBioscience.
FACSCalibur, BD Biosciences, San Jose, CA.
FlowJo software, TreeStar, San Carlos, CA.
The authors report no conflicts of interest related to this study.
References
- 1.Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428–435. doi: 10.1038/nature07201. [DOI] [PubMed] [Google Scholar]
- 2.Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: Current concepts. J Periodontol. 1992;63(Suppl 4):322–331. doi: 10.1902/jop.1992.63.4s.322. [DOI] [PubMed] [Google Scholar]
- 3.Byrne SJ, Dashper SG, Darby IB, Adams GG, Hoffmann B, Reynolds EC. Progression of chronic periodontitis can be predicted by the levels of Porphyromonas gingivalis and Treponema denticola in subgingival plaque. Oral Microbiol Immunol. 2009;24:469–477. doi: 10.1111/j.1399-302X.2009.00544.x. [DOI] [PubMed] [Google Scholar]
- 4.Craig RG, Yip JK, Mijares DQ, LeGeros RZ, Socransky SS, Haffajee AD. Progression of destructive periodontal diseases in three urban minority populations: Role of clinical and demographic factors. J Clin Periodontol. 2003;30:1075–1083. doi: 10.1046/j.0303-6979.2003.00421.x. [DOI] [PubMed] [Google Scholar]
- 5.Lamont RJ, Jenkinson HF. Life below the gum line: Pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev. 1998;62:1244–1263. doi: 10.1128/mmbr.62.4.1244-1263.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD. Relationship of destructive periodontal disease to the acute-phase response. J Periodontol. 2003;74:1007–1016. doi: 10.1902/jop.2003.74.7.1007. [DOI] [PubMed] [Google Scholar]
- 7.Pathirana RD, O’Brien-Simpson NM, Reynolds EC. Host immune responses to Porphyromonas gingivalis antigens. Periodontol 2000. 2010;52:218–237. doi: 10.1111/j.1600-0757.2009.00330.x. [DOI] [PubMed] [Google Scholar]
- 8.Hayashi C, Viereck J, Hua N, et al. Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice. Atherosclerosis. 2011;215:52–59. doi: 10.1016/j.atherosclerosis.2010.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Chen GY, Nuñez G. Sterile inflammation: Sensing and reacting to damage. Nat Rev Immunol. 2010;10:826–837. doi: 10.1038/nri2873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Underhill DM, Goodridge HS. Information processing during phagocytosis. Nat Rev Immunol. 2012;12:492–502. doi: 10.1038/nri3244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Gabay C, Lamacchia C, Palmer G. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 2010;6:232–241. doi: 10.1038/nrrheum.2010.4. [DOI] [PubMed] [Google Scholar]
- 12.Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL- 1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol. 1998;160:403–409. [PubMed] [Google Scholar]
- 13.Tanzer JM. Xylitol chewing gum and dental caries. Int Dent J. 1995;45(1 Suppl 1):65–76. [PubMed] [Google Scholar]
- 14.Lynch H, Milgrom P. Xylitol and dental caries: An overview for clinicians. J Calif Dent Assoc. 2003;31:205–209. [PubMed] [Google Scholar]
- 15.Milgrom P, Ly KA, Roberts MC, Rothen M, Mueller G, Yamaguchi DK. Mutans streptococci dose response to xylitol chewing gum. J Dent Res. 2006;85:177–181. doi: 10.1177/154405910608500212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Han SJ, Jeong SY, Nam YJ, Yang KH, Lim HS, Chung J. Xylitol inhibits inflammatory cytokine expression induced by lipopolysaccharide from Porphyromonas gingivalis. Clin Diagn Lab Immunol. 2005;12:1285–1291. doi: 10.1128/CDLI.12.11.1285-1291.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zhou Q, Amar S. Identification of proteins differentially expressed in human monocytes exposed to Porphyromonas gingivalis and its purified components by high-throughput immunoblotting. Infect Immun. 2006;74:1204–1214. doi: 10.1128/IAI.74.2.1204-1214.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–550. doi: 10.1146/annurev.immunol.021908.132612. [DOI] [PubMed] [Google Scholar]
- 19.Masada MP, Persson R, Kenney JS, Lee SW, Page RC, Allison AC. Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: Implications for the pathogenesis of periodontal disease. J Periodontal Res. 1990;25:156–163. doi: 10.1111/j.1600-0765.1990.tb01038.x. [DOI] [PubMed] [Google Scholar]
- 20.Stashenko P, Jandinski JJ, Fujiyoshi P, Rynar J, Socransky SS. Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol. 1991;62:504–509. doi: 10.1902/jop.1991.62.8.504. [DOI] [PubMed] [Google Scholar]
- 21.Yun PL, Decarlo AA, Collyer C, Hunter N. Hydrolysis of interleukin-12 by Porphyromonas gingivalis major cysteine proteinases may affect local gamma interferon accumulation and the Th1 or Th2 T-cell phenotype in periodontitis. Infect Immun. 2001;69:5650–5660. doi: 10.1128/IAI.69.9.5650-5660.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Tsai IS, Tsai CC, Ho YP, Ho KY, Wu YM, Hung CC. Interleukin-12 and interleukin-16 in periodontal disease. Cytokine. 2005;31:34–40. doi: 10.1016/j.cyto.2005.02.007. [DOI] [PubMed] [Google Scholar]
- 23.Costa GG, Silva RM, Franco-Penteado CF, Antunes E, Ferreira HH. Interactions between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils. Eur J Pharmacol. 2007;566:200–205. doi: 10.1016/j.ejphar.2006.09.075. [DOI] [PubMed] [Google Scholar]
- 24.de Queiroz AC, Taba M, Jr, O’Connell PA, et al. Inflammation markers in healthy and periodontitis patients: A preliminary data screening. Braz Dent J. 2008;19:3–8. doi: 10.1590/s0103-64402008000100001. [DOI] [PubMed] [Google Scholar]
- 25.Liu M, Guo S, Hibbert JM, et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 2011;22:121–130. doi: 10.1016/j.cytogfr.2011.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Loetscher M, Gerber B, Loetscher P, et al. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes. J Exp Med. 1996;184:963–969. doi: 10.1084/jem.184.3.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Emingil G, Atilla G, Hüseyinov A. Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis. J Clin Periodontol. 2004;31:829–834. doi: 10.1111/j.1600-051X.2004.00584.x. [DOI] [PubMed] [Google Scholar]
- 28.Kurtiş B, Tüter G, Serdar M, et al. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol. 2005;76:1849–1855. doi: 10.1902/jop.2005.76.11.1849. [DOI] [PubMed] [Google Scholar]
- 29.Pradeep AR, Daisy H, Hadge P, Garg G, Thorat M. Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease. J Periodontol. 2009;80:1454–1461. doi: 10.1902/jop.2009.090117. [DOI] [PubMed] [Google Scholar]
- 30.Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res. 2009;29:313–326. doi: 10.1089/jir.2008.0027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Maurer M, von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol. 2004;36:1882–1886. doi: 10.1016/j.biocel.2003.10.019. [DOI] [PubMed] [Google Scholar]
- 32.Gemmell E, Carter CL, Seymour GJ. Chemokines in human periodontal disease tissues. Clin Exp Immunol. 2001;125:134–141. doi: 10.1046/j.1365-2249.2001.01511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Cirino G, Distrutti E, Wallace JL. Nitric oxide and inflammation. Inflamm Allergy Drug Targets. 2006;5:115–119. doi: 10.2174/187152806776383143. [DOI] [PubMed] [Google Scholar]
- 34.Herrera BS, Martins-Porto R, Maia-Dantas A, et al. iNOS-derived nitric oxide stimulates osteoclast activity and alveolar bone loss in ligature-induced periodontitis in rats. J Periodontol. 2011;82:1608–1615. doi: 10.1902/jop.2011.100768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Menaka KB, Ramesh A, Thomas B, Kumari NS. Estimation of nitric oxide as an inflammatory marker in periodontitis. J Indian Soc Periodontol. 2009;13:75–78. doi: 10.4103/0972-124X.55842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL. Cutting edge: Inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol. 2006;177:2051–2055. doi: 10.4049/jimmunol.177.4.2051. [DOI] [PubMed] [Google Scholar]
- 37.Chen YJ, Hsieh MY, Chang MY, et al. Eps8 protein facilitates phagocytosis by increasing TLR4-MyD88 protein interaction in lipopolysaccharide-stimulated macrophages. J Biol Chem. 2012;287:18806–18819. doi: 10.1074/jbc.M112.340935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Deng M, Scott MJ, Loughran P, et al. Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis. J Immunol. 2013;190:5152–5160. doi: 10.4049/jimmunol.1300496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Redlich S, Ribes S, Schütze S, Eiffert H, Nau R. Toll-like receptor stimulation increases phagocytosis of Cryptococcus neoformans by microglial cells. J Neuroinflammation. 2013;10:71–77. doi: 10.1186/1742-2094-10-71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ribes S, Ebert S, Regen T, et al. Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect Immun. 2010;78:865–871. doi: 10.1128/IAI.01110-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Sun Y, Shu R, Li CL, Zhang MZ. Gram-negative periodontal bacteria induce the activation of Toll-like receptors 2 and 4, and cytokine production in human periodontal ligament cells. J Periodontol. 2010;81:1488–1496. doi: 10.1902/jop.2010.100004. [DOI] [PubMed] [Google Scholar]
- 42.Kikkert R, Laine ML, Aarden LA, van Winkelhoff AJ. Activation of toll-like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol Immunol. 2007;22:145–151. doi: 10.1111/j.1399-302X.2007.00335.x. [DOI] [PubMed] [Google Scholar]
- 43.June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today. 1994;15:321–331. doi: 10.1016/0167-5699(94)90080-9. [DOI] [PubMed] [Google Scholar]
- 44.Orima K, Yamazaki K, Aoyagi T, Hara K. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue. Clin Exp Immunol. 1999;115:153–160. doi: 10.1046/j.1365-2249.1999.00763.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Zhang P, Lewis JP, Michalek SM, Katz J. Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A. Vaccine. 2007;25:6201–6210. doi: 10.1016/j.vaccine.2007.05.066. [DOI] [PMC free article] [PubMed] [Google Scholar]






